… for Different Treatment Intensification Approaches in Patients with Type 2 Diabetes Uncontrolled on Basal Insulin: Adding Glucagon-Like Peptide-1 Receptor Agonists …
P Levin, T Fan, X Song, D Nero, B Davis… - Endocrine …, 2017 - journals.aace.com
Abstract Objective—Not all patients with type 2 diabetes achieve the recommended glycated
hemoglobin A1c (A1C) levels after adequate titration of basal insulin (BI). Current
intensification approaches include addition of rapid-acting insulin (RAI) or a glucagon-like
hemoglobin A1c (A1C) levels after adequate titration of basal insulin (BI). Current
intensification approaches include addition of rapid-acting insulin (RAI) or a glucagon-like
For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to ＞99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.
Quick Links:
Contact Information:
Eva He
eva@pepmic.com
Pepmic Co., Ltdeva@pepmic.com
www.pepmic.com
没有评论:
发表评论